Mutual Fund Details

UTI Healthcare Fund Direct-IDCW Reinvestment

Equity Pharma

NAV

₹251.8939

as on 06 Dec 2024, 11:15 PM

₹-0.5665(0.22%)

Last Change

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,82,889

₹1,88,715

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹88,715

Profit (absolute return)

88.72%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

2.31%

In the last 6 months

28.38%

In the last 1 year

48.09%

In the last 3 years

88.72%

In the last 5 years

263.65%

In the last 10 years

277.01%

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

UTI Healthcare Fund Direct-IDCW Reinvestment

as of 30 Nov 2024, 05:30 AM

₹1,203.23 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 30 days.

1.25%

Expense Ratio

Plan

Dividend

2.01%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 1% if redeemed within 30 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

97.43%

₹1,172.35 Cr

Cash Holding

2.00%

₹24.12 Cr

Insurance

1.04%

₹12.50 Cr

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

97.43%

₹1,172.35 Cr

Cash Holding

2.00%

₹24.12 Cr

Insurance

1.04%

₹12.50 Cr

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

11.34%

₹136.45 Cr

Cipla Ltd.

6.61%

₹79.53 Cr

Dr. Reddy's Laboratories Ltd.

5.66%

₹68.10 Cr

Ajanta Pharma Ltd.

5.29%

₹63.65 Cr

Apollo Hospitals Enterprise Ltd.

4.07%

₹48.97 Cr

Others

67.03%

₹806.52 Cr

View All

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

11.34%

₹136.45 Cr

Cipla Ltd.

6.61%

₹79.53 Cr

Dr. Reddy's Laboratories Ltd.

5.66%

₹68.10 Cr

Ajanta Pharma Ltd.

5.29%

₹63.65 Cr

Apollo Hospitals Enterprise Ltd.

4.07%

₹48.97 Cr

Others

67.03%

₹806.52 Cr

View All

Funds in this Category

This fund's returns:

23.55%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

DSP Healthcare Fund Direct - Growth

About UTI Healthcare Fund Direct-IDCW Reinvestment

UTI Healthcare Fund Direct-IDCW Reinvestment is a Equity mutual fund scheme from UTI Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹1,203.23 Crores and the latest NAV decalared is ₹251.894 as on 07 Dec 2024 at 4:31 pm.

UTI Healthcare Fund Direct-IDCW Reinvestment scheme return performance in last 1 year is 48.09%, in last 3 years is 88.72% and 583.01% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.